20.1
Can-Fite BioPharma Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
9.16
FY23:
9.91
FY24:
8.98
FY25:
9.44
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.19
FY22:
0.13
FY23:
0.08
FY24:
0.14
FY25:
0.07
Total assets
Change from FY21 to FY25
millions USD
FY21:
20.3
FY22:
9.28
FY23:
9.99
FY24:
9.12
FY25:
9.51
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.73
FY22:
2.50
FY23:
2.02
FY24:
2.05
FY25:
2.73
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.14
FY22:
2.31
FY23:
1.73
FY24:
1.63
FY25:
1.19
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.4
FY22:
4.47
FY23:
6.24
FY24:
5.44
FY25:
5.59
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
20.3
FY22:
9.28
FY23:
9.99
FY24:
9.12
FY25:
9.51
All amounts in millions USD